Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Mr. Verjee will take accountability for the U.S. and Canada biopharmaceutical business
August 31, 2018
By: Tim Wright
Editor-in-Chief, Contract Pharma
EMD Serono, the biopharmaceutical business of Merck KGaA in the U.S. and Canada, has appointed Rehan Verjee as president of EMD Serono and global head of innovative medicine franchises for Merck KGaA. “Uniting the leadership of North America with our Global Innovative Medicine Franchises will increasingly put North America at the heart of our strategy,” said Belén Garijo, chief executive officer, healthcare, Merck KGaA. “Rehan’s leadership experience and track record of working across commercial and R&D makes him perfectly suited to ensure we are well positioned to deliver on the promise of our innovative medicine efforts.” For the past three years, Mr. Verjee has been the executive vice president, chief marketing and strategy officer, healthcare, Merck KGaA. He was accountable for the global specialty franchises of infertility, oncology, and neurology and immunology, together with global market access, business development, strategy and portfolio management and the medical device and services unit. Prior to that, Mr. Verjee led the Canadian business as managing director. In his new role, Mr. Verjee will take accountability for the U.S. and Canada biopharmaceutical business, while maintaining global accountability for the oncology and neurology and immunology franchises. He will assume full responsibility of the new position starting September 1, 2018. Mr. Verjee succeeds Gary Zieziula, who has led the business first as chief commercial officer since January, 2014, and then as president, from January, 2016 until the present. Mr. Zieziula will remain with EMD Serono through the end of 2018 in support of the transition.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !